# REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue

> **NCT04525183** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 49 (actual)

## Conditions studied

- Ovarian Cancer
- Fatigue
- Coping Behavior
- Coping Skills

## Interventions

- **BEHAVIORAL:** Enhanced Usual Care (EOC)
- **BEHAVIORAL:** REVITALIZE ACT Intervention

## Key facts

- **NCT ID:** NCT04525183
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-02
- **Primary completion:** 2022-08-09
- **Final completion:** 2022-08-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-11-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04525183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04525183, "REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04525183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*